Effect of ursodeoxycholic acid on hepatic steatosis in rats

Digestive Diseases and Sciences

Volumn 47, Issue 11, 2002, Pages 2389-2397

  Okan, Abdullah ^a   Astarcioglu, Huseyin ^a   Tankurt, Ethem ^a   Sagol, Ozgul ^a   Altekin, Emel ^a   Astarcioglu, Ibrahim ^a   Gonen, Omur ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Choline deficient diet; Fatty liver; Steatosis; Ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; FATTY LIVER; HISTOPATHOLOGY; LIPID VESICLE; LIVER BIOPSY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; STEATOSIS; TREATMENT OUTCOME;

ANIMALS; CHOLAGOGUES AND CHOLERETICS; FATTY LIVER; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; URSODEOXYCHOLIC ACID;

EID: 0036844111     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020523017873     Document Type: Article

References (29)

1. Zakim D: Metabolism of glucose and fatty acids by the liver. In Hepatology, A Textbook of Liver Disease. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1996, pp 58-92
2. Vierling JM: Hepatobiliary complications of ulcerative colitis and Crohns disease. In Hepatology, A Textbook of Liver Disease. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1996, pp 1366-1405
3. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Host and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29:198-206, 1998
4. Sherlock S, Dooley J: Nutritional and metabolic liver diseases. In Diseases of the Liver and Biliary System. S Sherlock, J Dooley (eds). Portland, Blackwell Science Inc, 1997, pp 427-433
5. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA: Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 107:1103-1109, 1994
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough J: Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 116:1413-1419, 1999
7. Makino I, Shinozaki K, Yoshino K, Nakagawa S: Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid. Nippon Shokakibyo Gakkai Zasshi 72:690-702, 1975
8. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW: Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 319:1567-1572, 1988
9. Heuman DM, Pandak WM, Hylemon PB, Vlahzevic ZR: Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts. Hepatology 14:920-926, 1991
10. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284-1290, 1994
11. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L: Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 20:57-64, 1994
12. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB: Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study. Hepatology 23:1464-1467, 1996
13. Puoti C, Pannullo A, Annovazzi G, Filippi T, Magrini A: Ursodeoxycholic acid and chronic hepatitis C infection. Lancet 341:1413-1414, 1993
14. Fabbri C, Marchetto S, Pezzoli A, Accogli E, Fusaroli P, Azzaroli F, Jaboli MF, Mazzeo C, Montagnani M, Festi D, Roda E, Mazzella G: Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients. Eur J Gastroenterol Hepatol 12:511-515, 2000
15. Janowitz P, Kratzer W, Wechsler JG: Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity - A pilot study. Leber Magen Darm 26:310-313, 1996
16. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JV, Powell LW: The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 11:74-80, 1990
17. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H: Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 79:131-137, 1980
18. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB: Does long-term home parenteral nutrition in adult patients cause chronic liver disease? JPEN 9:11-17, 1985
19. Ludwig J, Mcgill DB, Lindor KD: Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12:398-403, 1997
20. Shronts EP: The role of choline in parenteral nutrition induced liver dysfunction. Rev Bras Nutr Clin 12:41-48, 1997
21. Lombardi B, Pani P, Schlunk FF: Choline deficiency fatty liver. Impaired release of hepatic triglycerides. J Lipid Res 9:437-446, 1968
22. Yao ZM, Vance DE: The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 263:2998-3004, 1988
23. Einarsson K, Bjorkhem I, Eklof R, Ewerth S, Nilsell K, Blomstrand R: Effect of ursodeoxycholic acid treatment on intestinal absorption of triglycerides in man. Scand J Gastroenterol 19:283-288, 1984
24. Tabouy L, Zamora AJ, Oliva L, Montet AM, Beauge F, Montet JC: Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci 63:2259-2270, 1998
25. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D: Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 24:200-208, 1996
26. Pinto HC, Felipe P, Baptista A, Fernandes A, Camilho E, Ramalho F, Moura MC: Hepatic steatosis and lipid peroxidation in human chronic liver diseases. Hepatology 24:311A, 1996 (abstract)
27. Berson A, De Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D: Steatohepatitis-inducing drugs cause mitochondral dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764-774, 1998
28. Day CP, James OFW: Steatohepatitis: A tale of two hits. Gastroenterology 114:842-845, 1998
29. Oliva L, Beauge F, Choquart D, Montet AM, Guitaoui M, Montet JC: Ursodeoxycholate alleviates alcoholic fatty liver damage in rats. Alcohol Clin Exp Res 22:1538-1543, 1998